These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 27941362)
1. Molecular characterization of endometrial cancer and therapeutic implications. Uppendahl L; Mullany SA; Winterhoff B Curr Opin Obstet Gynecol; 2017 Feb; 29(1):35-39. PubMed ID: 27941362 [TBL] [Abstract][Full Text] [Related]
2. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups. Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706 [TBL] [Abstract][Full Text] [Related]
3. Molecular Genetics of Endometrial Carcinoma. Bell DW; Ellenson LH Annu Rev Pathol; 2019 Jan; 14():339-367. PubMed ID: 30332563 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and Genomic Analysis of Momeni-Boroujeni A; Dahoud W; Vanderbilt CM; Chiang S; Murali R; Rios-Doria EV; Alektiar KM; Aghajanian C; Abu-Rustum NR; Ladanyi M; Ellenson LH; Weigelt B; Soslow RA Clin Cancer Res; 2021 May; 27(9):2613-2623. PubMed ID: 33602681 [TBL] [Abstract][Full Text] [Related]
5. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression. Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of endometrial cancer and therapeutic implications. Winterhoff B; Thomaier L; Mullany S; Powell MA Curr Opin Obstet Gynecol; 2020 Feb; 32(1):76-83. PubMed ID: 31851045 [TBL] [Abstract][Full Text] [Related]
7. Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology. Akhtar M; Al Hyassat S; Elaiwy O; Rashid S; Al-Nabet ADMH Adv Anat Pathol; 2019 Nov; 26(6):421-427. PubMed ID: 31567131 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of endometrial cancer and therapeutic implications. Chang Z; Talukdar S; Mullany SA; Winterhoff B Curr Opin Obstet Gynecol; 2019 Feb; 31(1):24-30. PubMed ID: 30507624 [TBL] [Abstract][Full Text] [Related]
9. The emerging genomic landscape of endometrial cancer. Le Gallo M; Bell DW Clin Chem; 2014 Jan; 60(1):98-110. PubMed ID: 24170611 [TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging. Espinosa I; D'Angelo E; Prat J Gynecol Oncol; 2024 Jul; 186():94-103. PubMed ID: 38615479 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1. Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824 [TBL] [Abstract][Full Text] [Related]
13. [Current prerequisites for a molecular genetic classification of endometrial cancer]. Vtorushin SV; Malykh RD Arkh Patol; 2017; 79(3):57-62. PubMed ID: 28631718 [TBL] [Abstract][Full Text] [Related]
14. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Koul A; Willén R; Bendahl PO; Nilbert M; Borg A Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy. Prendergast EN; Holman LL; Liu AY; Lai TS; Campos MP; Fahey JN; Wang X; Abdelaal N; Rao JY; Elvin JA; Moore KM; Konecny GE; Cohen JG Gynecol Oncol; 2019 Sep; 154(3):461-466. PubMed ID: 31257009 [TBL] [Abstract][Full Text] [Related]
16. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma. Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776 [TBL] [Abstract][Full Text] [Related]
17. Reclassifying endometrial carcinomas with a combined morphological and molecular approach. Carlson J; McCluggage WG Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170 [TBL] [Abstract][Full Text] [Related]
18. Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer. Walker CJ; Miranda MA; O'Hern MJ; McElroy JP; Coombes KR; Bundschuh R; Cohn DE; Mutch DG; Goodfellow PJ J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26330387 [TBL] [Abstract][Full Text] [Related]
19. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers. Schultheis AM; Martelotto LG; De Filippo MR; Piscuglio S; Ng CK; Hussein YR; Reis-Filho JS; Soslow RA; Weigelt B Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035 [TBL] [Abstract][Full Text] [Related]
20. Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability. Thoury A; Descatoire V; Kotelevets L; Kannengiesser C; Bertrand G; Theou-Anton N; Frey C; Genestie C; Raymond E; Chastre E; Lehy T; Walker F Histol Histopathol; 2014 Nov; 29(11):1455-66. PubMed ID: 24811063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]